{"id":7994,"date":"2026-02-27T11:43:09","date_gmt":"2026-02-27T09:43:09","guid":{"rendered":"https:\/\/www.msd.ch\/fr\/?page_id=7994"},"modified":"2026-02-27T11:43:22","modified_gmt":"2026-02-27T09:43:22","slug":"winrevair-publication-of-clinical-trial-results","status":"publish","type":"page","link":"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/","title":{"rendered":"WINREVAIR\u00ae &#8211; Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques<\/h1>\n\n\n\n<p>Les informations ci-dessous ainsi que les liens correspondant aux donn\u00e9es cliniques r\u00e9pondent aux exigences des articles 71 \u00e0 73 de l\u2019Ordonnance sur les m\u00e9dicaments (Ordonnance sur les m\u00e9dicaments, OM\u00e9d) et compl\u00e8tent les informations publi\u00e9es en lien avec l\u2019autorisation suisse des m\u00e9dicaments correspondants.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">WINREVAIR\u00ae<\/h2>\n\n\n\n<p>Winrevair\u00ae (Sotatercept), un flacon de poudre pour solution injectable contient 45&nbsp;mg ou 60&nbsp;mg de sotatercept.<\/p>\n\n\n\n<p>Num\u00e9ro d\u2019autorisation: 69787<\/p>\n\n\n\n<p>Date d&#8217;autorisation par Swissmedic: 16 octobre 2024<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><br>\u00c9tudes d&#8217;admission:<\/h4>\n\n\n\n<p>PULSAR &#8211; NCT03496207: <a href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2017-004738-27\/results\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">EudraCT Number 2017-004738-27 &#8211; Clinical trial results &#8211; EU Clinical Trials Register<\/a><\/p>\n\n\n\n<p>STELLAR \u2013 NCT04576988: <a href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-004142-11\/results#resultContent\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">EudraCT Number 2020-004142-11 &#8211; Clinical trial results &#8211; EU Clinical Trials Register<\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Publications:<\/h4>\n\n\n\n<p>Humbert M, et al. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2021;384(13):1204-1215. DOI: 10.1056\/NEJMoa2024277.<\/p>\n\n\n\n<p>Hoeper MM et al. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med;2023;388(16):1478-1490. DOI: 10.1056\/NEJMoa2213558.<\/p>\n\n\n\n<p><sup>CH-SOT-00102, 02\/2026<\/sup><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques Les informations ci-dessous ainsi que les liens correspondant aux donn\u00e9es cliniques r\u00e9pondent aux exigences des articles 71 \u00e0 73 de l\u2019Ordonnance sur les m\u00e9dicaments (Ordonnance sur les m\u00e9dicaments, OM\u00e9d) et compl\u00e8tent les informations publi\u00e9es en lien avec l\u2019autorisation suisse des m\u00e9dicaments correspondants. WINREVAIR\u00ae Winrevair\u00ae (Sotatercept), un flacon de poudre pour [&hellip;]<\/p>\n","protected":false},"author":974,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"editor_notices":[],"footnotes":""},"class_list":["post-7994","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.9.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>WINREVAIR\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch<\/title>\n<meta name=\"description\" content=\"Publication des r\u00e9sultats des \u00e9tudes cliniques sur WINREVAIR, qui a \u00e9t\u00e9 autoris\u00e9 par Swissmedic le 13 septembre 2024.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WINREVAIR\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch\" \/>\n<meta property=\"og:description\" content=\"Publication des r\u00e9sultats des \u00e9tudes cliniques sur WINREVAIR, qui a \u00e9t\u00e9 autoris\u00e9 par Swissmedic le 13 septembre 2024.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"msd.ch\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-27T09:43:22+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/\",\"url\":\"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/\",\"name\":\"WINREVAIR\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch\",\"isPartOf\":{\"@id\":\"https:\/\/www.msd.ch\/fr\/#website\"},\"datePublished\":\"2026-02-27T09:43:09+00:00\",\"dateModified\":\"2026-02-27T09:43:22+00:00\",\"description\":\"Publication des r\u00e9sultats des \u00e9tudes cliniques sur WINREVAIR, qui a \u00e9t\u00e9 autoris\u00e9 par Swissmedic le 13 septembre 2024.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.msd.ch\/fr\/#website\",\"url\":\"https:\/\/www.msd.ch\/fr\/\",\"name\":\"msd.ch\",\"description\":\"MSD recherche et d\u00e9veloppe des m\u00e9dicaments et des vaccins pour sauver des vies et am\u00e9liorer la sant\u00e9 des patients. En Suisse, 1000 employ\u00e9s \u00e0 Lucerne et \u00e0 Zurich s&#039;engagent dans ce sens.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.msd.ch\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WINREVAIR\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","description":"Publication des r\u00e9sultats des \u00e9tudes cliniques sur WINREVAIR, qui a \u00e9t\u00e9 autoris\u00e9 par Swissmedic le 13 septembre 2024.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/","og_locale":"en_US","og_type":"article","og_title":"WINREVAIR\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","og_description":"Publication des r\u00e9sultats des \u00e9tudes cliniques sur WINREVAIR, qui a \u00e9t\u00e9 autoris\u00e9 par Swissmedic le 13 septembre 2024.","og_url":"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/","og_site_name":"msd.ch","article_modified_time":"2026-02-27T09:43:22+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/","url":"https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/","name":"WINREVAIR\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","isPartOf":{"@id":"https:\/\/www.msd.ch\/fr\/#website"},"datePublished":"2026-02-27T09:43:09+00:00","dateModified":"2026-02-27T09:43:22+00:00","description":"Publication des r\u00e9sultats des \u00e9tudes cliniques sur WINREVAIR, qui a \u00e9t\u00e9 autoris\u00e9 par Swissmedic le 13 septembre 2024.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.msd.ch\/fr\/winrevair-publication-of-clinical-trial-results\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.msd.ch\/fr\/#website","url":"https:\/\/www.msd.ch\/fr\/","name":"msd.ch","description":"MSD recherche et d\u00e9veloppe des m\u00e9dicaments et des vaccins pour sauver des vies et am\u00e9liorer la sant\u00e9 des patients. En Suisse, 1000 employ\u00e9s \u00e0 Lucerne et \u00e0 Zurich s&#039;engagent dans ce sens.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.msd.ch\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/7994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/users\/974"}],"replies":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/comments?post=7994"}],"version-history":[{"count":3,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/7994\/revisions"}],"predecessor-version":[{"id":9044,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/7994\/revisions\/9044"}],"wp:attachment":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/media?parent=7994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}